2.24
1.82%
0.04
시장 영업 전:
2.19
-0.05
-2.23%
전일 마감가:
$2.20
열려 있는:
$2.19
하루 거래량:
527.85K
Relative Volume:
0.71
시가총액:
$126.75M
수익:
-
순이익/손실:
$-82.44M
주가수익비율:
-1.1915
EPS:
-1.88
순현금흐름:
$-66.75M
1주 성능:
-0.44%
1개월 성능:
+0.90%
6개월 성능:
-61.04%
1년 성능:
-18.84%
Black Diamond Therapeutics Inc Stock (BDTX) Company Profile
명칭
Black Diamond Therapeutics Inc
전화
617-417-5868
주소
ONE MAIN STREET, 14TH FLOOR, CAMBRIDGE, MA
BDTX을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
BDTX
Black Diamond Therapeutics Inc
|
2.24 | 126.75M | 0 | -82.44M | -66.75M | -1.88 |
VRTX
Vertex Pharmaceuticals Inc
|
427.89 | 110.19B | 10.63B | -479.80M | -1.35B | -1.99 |
REGN
Regeneron Pharmaceuticals Inc
|
687.80 | 75.58B | 13.85B | 4.65B | 3.32B | 40.41 |
ARGX
Argen X Se Adr
|
647.39 | 38.71B | 1.86B | -40.29M | -1.28B | -0.85 |
ALNY
Alnylam Pharmaceuticals Inc
|
264.99 | 34.18B | 2.09B | -332.26M | 16.06M | -2.62 |
BNTX
Biontech Se Adr
|
117.25 | 28.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Black Diamond Therapeutics Inc Stock (BDTX) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-07-31 | 개시 | Raymond James | Outperform |
2023-07-14 | 개시 | Piper Sandler | Overweight |
2023-06-30 | 업그레이드 | Stifel | Hold → Buy |
2023-06-28 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
2023-06-27 | 업그레이드 | Wedbush | Neutral → Outperform |
2022-03-29 | 다운그레이드 | Wedbush | Outperform → Neutral |
2022-03-22 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
2021-09-30 | 개시 | Stifel | Hold |
2021-01-07 | 개시 | Wedbush | Outperform |
2020-11-24 | 개시 | Berenberg | Buy |
2020-05-04 | 개시 | H.C. Wainwright | Buy |
2020-02-24 | 개시 | Canaccord Genuity | Buy |
2020-02-24 | 개시 | Cowen | Outperform |
2020-02-24 | 개시 | JP Morgan | Overweight |
2020-02-24 | 개시 | Jefferies | Buy |
모두보기
Black Diamond Therapeutics Inc 주식(BDTX)의 최신 뉴스
Barclays PLC Has $339,000 Holdings in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Critical Comparison: Black Diamond Therapeutics (NASDAQ:BDTX) & Cardiol Therapeutics (NASDAQ:CRDL) - Defense World
3 US Penny Stocks With Market Caps Under $200M - Simply Wall St
Why Sage Therapeutics Shares Are Trading Higher By Over 34%; Here Are 20 Stocks Moving Premarket - Benzinga
Raymond James Predicts Up to ~930% Rally for These 2 ‘Strong Buy’ Stocks - Yahoo Finance
Are Medical Stocks Lagging Aptevo Therapeutics (APVO) This Year? - Yahoo Finance
BDTX stock touches 52-week low at $2.08 amid market challenges - Investing.com
BDTX stock touches 52-week low at $2.08 amid market challenges By Investing.com - Investing.com South Africa
Roche purchases shares in tender offer for Poseida Therapeutics, Inc. - Yahoo Finance
Soleno Therapeutics, Inc. (NASDAQ:SLNO): When Will It Breakeven? - Yahoo Finance
XORTX Adds Late Stage Gout Program to Pipeline - Yahoo Finance
Geode Capital Management LLC Raises Holdings in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Geode Capital Management LLC Grows Stock Holdings in BARK, Inc. (NYSE:BARK) - Defense World
Barclays PLC Acquires 11,273 Shares of Acrivon Therapeutics, Inc. (NASDAQ:ACRV) - Defense World
Geode Capital Management LLC Buys 50,579 Shares of Design Therapeutics, Inc. (NASDAQ:DSGN) - Defense World
Barclays PLC Has $339,000 Stock Holdings in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Why Is Summit Therapeutics Inc. (SMMT) Among the Best Multibagger Stocks to Buy Right Now? - Yahoo Finance
State Street Corp Buys 118,764 Shares of Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Black Diamond Therapeutics: Speculative Buy With Precision Oncology Catalysts (BDTX) - Seeking Alpha
Barclays PLC Has $1.10 Million Holdings in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) - Defense World
Sarepta Therapeutics, Inc. (SRPT): Is This Gene Therapy Stock a Good Buy Right Now? - Yahoo Finance
Analysts Expect Breakeven For Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Before Long - Yahoo Finance
Will TG Therapeutics, Inc. (TGTX) Make You Rich In 2025? - Yahoo Finance
Is Sarepta Therapeutics, Inc. (SRPT) the Best Performing Biotech Stock in 2024? - Yahoo Finance
Aligos Therapeutics, Inc.'s (NASDAQ:ALGS) biggest owners are retail investors who got richer after stock soared 17% last week - Yahoo Finance
Charles Schwab Investment Management Inc. Boosts Stock Position in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
BDTX stock touches 52-week low at $2.31 amid market challenges - Investing.com India
Analytical Overview: Black Diamond Therapeutics Inc (BDTX)’s Ratios Tell a Financial Story - The Dwinnex
Fmr LLC Makes New Investment in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Akava Therapeutics, Inc. congratulates SAB Chair Dr. Hande Ozdinler, Founder Dr. Richard B. Silverman, and Dr. William Klein on their recent grant of $7.3 million from the National Institute on Aging to investigate AKV9 in neurodegenerative diseases - Yahoo Finance
Sarepta Therapeutics, Inc. (SRPT): A Bull Case Theory - Yahoo Finance
US Penny Stocks Spotlight: Information Services Group Among 3 Top Picks - Simply Wall St
Black Diamond (BDTX) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Fmr LLC Decreases Stock Position in Mobileye Global Inc. (NASDAQ:MBLY) - Defense World
MFA Financial, Inc. (NYSE:MFA) Shares Sold by Fmr LLC - Defense World
BNP Paribas Financial Markets Purchases 111,027 Shares of Under Armour, Inc. (NYSE:UA) - Defense World
Fmr LLC Has $15.49 Million Stake in Schrödinger, Inc. (NASDAQ:SDGR) - Defense World
MetLife Investment Management LLC Raises Stake in Smith-Midland Co. (NASDAQ:SMID) - Defense World
BNP Paribas Financial Markets Raises Stake in RadNet, Inc. (NASDAQ:RDNT) - Defense World
Fmr LLC Increases Position in AppFolio, Inc. (NASDAQ:APPF) - Defense World
Fmr LLC Raises Stock Position in ADT Inc. (NYSE:ADT) - Defense World
Charles Schwab Investment Management Inc. Sells 309,336 Shares of Unisys Co. (NYSE:UIS) - Defense World
Oruka Therapeutics, Inc. (NASDAQ:ORKA) institutional investors have had a good week as stock gains 15% - Yahoo Finance
Point72 Asset Management L.P. Takes $3.03 Million Position in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - MarketBeat
Zevra Therapeutics, Inc. (NASDAQ:ZVRA) has caught the attention of institutional investors who hold a sizeable 42% stake - Yahoo Finance
The number of Black Fortune 500 CEOs is still abysmally low. A ‘shocking’ corporate DEI practice might be to blame, Stanford professor says - Yahoo Finance
vTv Therapeutics to Participate in 7th Annual Evercore HealthCONx Conference - Yahoo Finance
Vestal Point Capital LP Purchases 2,928,500 Shares of Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - MarketBeat
Gene and Cell Therapies Targeting CNS Disorders Treatment Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Medication, Revenue, Statistics, Therapies, Prevalence, Companies by DelveInsight - The Globe and Mail
Gene and Cell Therapies Targeting CNS Disorders Treatment - openPR
Breakeven On The Horizon For Unicycive Therapeutics, Inc. (NASDAQ:UNCY) - Yahoo Finance
Black Diamond Therapeutics Inc (BDTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):